-
1
-
-
0036467661
-
Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols
-
Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20:776-90.
-
(2002)
J Clin Oncol
, vol.20
, pp. 776-790
-
-
Bielack, S.S.1
Kempf-Bielack, B.2
Delling, G.3
Exner, G.U.4
Flege, S.5
Helmke, K.6
-
2
-
-
65549092332
-
Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma
-
Kim MS, Lee SY, Lee TR, Cho WH, Song WS, Koh JS, et al. Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma. Ann Oncol. 2009;20:955-60.
-
(2009)
Ann Oncol
, vol.20
, pp. 955-960
-
-
Kim, M.S.1
Lee, S.Y.2
Lee, T.R.3
Cho, W.H.4
Song, W.S.5
Koh, J.S.6
-
3
-
-
0018650014
-
Primary osteogenic sarcoma: The rationale for preoperative chemotherapy and delayed surgery
-
Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C, Huvos AG. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer. 1979;43:2163-77.
-
(1979)
Cancer
, vol.43
, pp. 2163-2177
-
-
Rosen, G.1
Marcove, R.C.2
Caparros, B.3
Nirenberg, A.4
Kosloff, C.5
Huvos, A.G.6
-
4
-
-
0020059356
-
Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy
-
Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer. 1982;49:1221-30.
-
(1982)
Cancer
, vol.49
, pp. 1221-1230
-
-
Rosen, G.1
Caparros, B.2
Huvos, A.G.3
Kosloff, C.4
Nirenberg, A.5
Cacavio, A.6
-
6
-
-
0027168772
-
Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D- glucose
-
Hoh CK, Hawkins RA, Glaspy JA, Dahlbom M, Tse NY, Hoffman EJ, et al. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose. J Comput Assist Tomogr. 1993;17:582-9.
-
(1993)
J Comput Assist Tomogr
, vol.17
, pp. 582-589
-
-
Hoh, C.K.1
Hawkins, R.A.2
Glaspy, J.A.3
Dahlbom, M.4
Tse, N.Y.5
Hoffman, E.J.6
-
7
-
-
48749118413
-
Response of osteogenic sarcoma to neoadjuvant therapy: Evaluated by 18FFDG- PET
-
Ye Z, Zhu J, Tian M, Zhang H, Zhan H, Zhao C, et al. Response of osteogenic sarcoma to neoadjuvant therapy: evaluated by 18FFDG- PET. Ann Nucl Med. 2008;22:475-80.
-
(2008)
Ann Nucl Med
, vol.22
, pp. 475-480
-
-
Ye, Z.1
Zhu, J.2
Tian, M.3
Zhang, H.4
Zhan, H.5
Zhao, C.6
-
8
-
-
0037096805
-
Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography
-
Hawkins DS, Rajendran JG, Conrad 3rd EU, Bruckner JD, Eary JF. Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D- glucose positron emission tomography. Cancer. 2002;94:3277-84.
-
(2002)
Cancer
, vol.94
, pp. 3277-3284
-
-
Hawkins, D.S.1
Rajendran, J.G.2
Conrad III, E.U.3
Bruckner, J.D.4
Eary, J.F.5
-
9
-
-
0036326395
-
Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma
-
Franzius C, Bielack S, Flege S, Sciuk J, Jurgens H, Schober O. Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma. J Nucl Med. 2002;43:1012-7.
-
(2002)
J Nucl Med
, vol.43
, pp. 1012-1017
-
-
Franzius, C.1
Bielack, S.2
Flege, S.3
Sciuk, J.4
Jurgens, H.5
Schober, O.6
-
10
-
-
0032888794
-
Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET
-
Schulte M, Brecht-Krauss D, Werner M, Hartwig E, Sarkar MR, Keppler P, et al. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET. J Nucl Med. 1999;40:1637-43.
-
(1999)
J Nucl Med
, vol.40
, pp. 1637-1643
-
-
Schulte, M.1
Brecht-Krauss, D.2
Werner, M.3
Hartwig, E.4
Sarkar, M.R.5
Keppler, P.6
-
11
-
-
80053350449
-
Prediction of chemotherapy response by PET-CT in osteosarcoma: Correlation with histologic necrosis
-
Bajpai J, Kumar R, Sreenivas V, Chand Sharma M, Khan SA, Rastogi S, et al. Prediction of chemotherapy response by PET-CT in osteosarcoma: correlation with histologic necrosis. J Pediatr Hematol Oncol. 2011;33:e271-8.
-
(2011)
J Pediatr Hematol Oncol
, vol.33
-
-
Bajpai, J.1
Kumar, R.2
Sreenivas, V.3
Chand Sharma, M.4
Khan, S.A.5
Rastogi, S.6
-
12
-
-
46749118451
-
Treatment monitoring by 18FFDG PET/CT in patients with sarcomas: Interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors
-
Benz MR, Evilevitch V, Allen-Auerbach MS, Eilber FC, Phelps ME, Czernin J, et al. Treatment monitoring by 18FFDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors. J Nucl Med. 2008;49:1038-46.
-
(2008)
J Nucl Med
, vol.49
, pp. 1038-1046
-
-
Benz, M.R.1
Evilevitch, V.2
Allen-Auerbach, M.S.3
Eilber, F.C.4
Phelps, M.E.5
Czernin, J.6
-
13
-
-
77949424147
-
Tumor necrosis in osteosarcoma: Inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis
-
Costelloe CM, Raymond AK, Fitzgerald NE, Mawlawi OR, Nunez RF, Madewell JE, et al. Tumor necrosis in osteosarcoma: inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis. Skeletal Radiol. 2010;39:131-40.
-
(2010)
Skeletal Radiol
, vol.39
, pp. 131-140
-
-
Costelloe, C.M.1
Raymond, A.K.2
Fitzgerald, N.E.3
Mawlawi, O.R.4
Nunez, R.F.5
Madewell, J.E.6
-
14
-
-
39149096261
-
Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients
-
Kim MS, Lee SY, Cho WH, Song WS, Koh JS, Lee JA, et al. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients. Ann Surg Oncol. 2008;15:906-14.
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 906-914
-
-
Kim, M.S.1
Lee, S.Y.2
Cho, W.H.3
Song, W.S.4
Koh, J.S.5
Lee, J.A.6
-
15
-
-
0020514629
-
Primary osteogenic sarcoma: Eight-year experience with adjuvant chemotherapy
-
Rosen G, Marcove RC, Huvos AG, Caparros BI, Lane JM, Nirenberg A, et al. Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy. J Cancer Res Clin Oncol. 1983;106 Suppl:55-67.
-
(1983)
J Cancer Res Clin Oncol
, vol.106
, Issue.SUPPL.
, pp. 55-67
-
-
Rosen, G.1
Marcove, R.C.2
Huvos, A.G.3
Caparros, B.I.4
Lane, J.M.5
Nirenberg, A.6
-
16
-
-
11244336678
-
Treatment effects in pediatric soft tissue and bone tumors: Practical considerations for the pathologist
-
Coffin CM, Lowichik A, Zhou H. Treatment effects in pediatric soft tissue and bone tumors: practical considerations for the pathologist. Am J Clin Pathol. 2005;123:75-90.
-
(2005)
Am J Clin Pathol
, vol.123
, pp. 75-90
-
-
Coffin, C.M.1
Lowichik, A.2
Zhou, H.3
-
17
-
-
0023151868
-
Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents
-
Göbel V, Jürgens H, Etspüler G, Kemperdick H, Jungblut RM, Stienen U, et al. Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents. J Cancer Res Clin Oncol. 1987;113:187-91.
-
(1987)
J Cancer Res Clin Oncol
, vol.113
, pp. 187-191
-
-
Göbel, V.1
Jürgens, H.2
Etspüler, G.3
Kemperdick, H.4
Jungblut, R.M.5
Stienen, U.6
-
18
-
-
9044249330
-
Tumor size and prognosis in aggressively treated osteosarcoma
-
Bieling P, Rehan N, Winkler P, Helmke K, Maas R, Fuchs N, et al. Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol. 1996;14:848-58.
-
(1996)
J Clin Oncol
, vol.14
, pp. 848-858
-
-
Bieling, P.1
Rehan, N.2
Winkler, P.3
Helmke, K.4
Maas, R.5
Fuchs, N.6
-
19
-
-
55749105515
-
An examination of the efficacy of the 8 cm maximal tumor diameter cutoff for the subdivision of AJCC stage II osteosarcoma patients
-
Kim MS, Lee SY, Cho WH, Song WS, Koh JS, Lee JA, et al. An examination of the efficacy of the 8 cm maximal tumor diameter cutoff for the subdivision of AJCC stage II osteosarcoma patients. J Surg Oncol. 2008;98:427-31.
-
(2008)
J Surg Oncol
, vol.98
, pp. 427-431
-
-
Kim, M.S.1
Lee, S.Y.2
Cho, W.H.3
Song, W.S.4
Koh, J.S.5
Lee, J.A.6
-
20
-
-
0033787602
-
Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis
-
Franzius C, Sciuk J, Brinkschmidt C, Jurgens H, Schober O. Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clin Nucl Med. 2000;25:874-81.
-
(2000)
Clin Nucl Med
, vol.25
, pp. 874-881
-
-
Franzius, C.1
Sciuk, J.2
Brinkschmidt, C.3
Jurgens, H.4
Schober, O.5
-
21
-
-
33748507112
-
Comparison between F-18-FDG positron emission tomography and histology for the assessment of tumor necrosis rates in primary osteosarcoma
-
Huang TL, Liu RS, Chen TH, Chen WY, Hsu HC, Hsu YC. Comparison between F-18-FDG positron emission tomography and histology for the assessment of tumor necrosis rates in primary osteosarcoma. J Chin Med Assoc. 2006;69:372-6.
-
(2006)
J Chin Med Assoc
, vol.69
, pp. 372-376
-
-
Huang, T.L.1
Liu, R.S.2
Chen, T.H.3
Chen, W.Y.4
Hsu, H.C.5
Hsu, Y.C.6
-
22
-
-
66149139452
-
From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors
-
Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50 Suppl 1:122S-50.
-
(2009)
J Nucl Med
, vol.50
, Issue.SUPPL. 1
-
-
Wahl, R.L.1
Jacene, H.2
Kasamon, Y.3
Lodge, M.A.4
-
24
-
-
84855409217
-
Impact of the definition of peak standardized uptake value on quantification of treatment response
-
Vanderhoek M, Perlman SB, Jeraj R. Impact of the definition of peak standardized uptake value on quantification of treatment response. J Nucl Med. 2012;53:4-11.
-
(2012)
J Nucl Med
, vol.53
, pp. 4-11
-
-
Vanderhoek, M.1
Perlman, S.B.2
Jeraj, R.3
-
26
-
-
76249120902
-
Early (18)F-2-fluoro-2-deoxy-d-glucose positron emission tomography may identify a subset of patients with estrogen receptor-positive breast cancer who will not respond optimally to preoperative chemotherapy
-
Martoni AA, Zamagni C, Quercia S, Rosati M, Cacciari N, Bernardi A, et al. Early (18)F-2-fluoro-2-deoxy-d-glucose positron emission tomography may identify a subset of patients with estrogen receptor-positive breast cancer who will not respond optimally to preoperative chemotherapy. Cancer. 2010;116:805-13.
-
(2010)
Cancer
, vol.116
, pp. 805-813
-
-
Martoni, A.A.1
Zamagni, C.2
Quercia, S.3
Rosati, M.4
Cacciari, N.5
Bernardi, A.6
-
27
-
-
67349209897
-
18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
-
18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Eur Radiol. 2009;19:1347-57.
-
(2009)
Eur Radiol
, vol.19
, pp. 1347-1357
-
-
Kumar, A.1
Kumar, R.2
Seenu, V.3
Gupta, S.D.4
Chawla, M.5
Malhotra, A.6
-
28
-
-
77950985227
-
Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer
-
Lee HY, Lee HJ, Kim YT, Kang CH, Jang BG, Chung DH, et al. Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer. J Thorac Oncol. 2010;5:497-503.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 497-503
-
-
Lee, H.Y.1
Lee, H.J.2
Kim, Y.T.3
Kang, C.H.4
Jang, B.G.5
Chung, D.H.6
-
30
-
-
78649318716
-
High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinoma
-
Chung HW, Lee EJ, Cho YH, Yoon SY, So Y, Kim SY, et al. High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinoma. J Cancer Res Clin Oncol. 2010;136:1929-35.
-
(2010)
J Cancer Res Clin Oncol
, vol.136
, pp. 1929-1935
-
-
Chung, H.W.1
Lee, E.J.2
Cho, Y.H.3
Yoon, S.Y.4
So, Y.5
Kim, S.Y.6
-
31
-
-
68149150875
-
[F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults
-
Hawkins DS, Conrad 3rd EU, Butrynski JE, Schuetze SM, Eary JF. [F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults. Cancer. 2009;115:3519-25.
-
(2009)
Cancer
, vol.115
, pp. 3519-3525
-
-
Hawkins, D.S.1
Conrad III, E.U.2
Butrynski, J.E.3
Schuetze, S.M.4
Eary, J.F.5
-
32
-
-
84858781687
-
18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma
-
18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma. Eur J Nucl Med Mol Imaging. 2012;39:39-49.
-
(2012)
Eur J Nucl Med Mol Imaging
, vol.39
, pp. 39-49
-
-
Im, H.J.1
Kim, T.S.2
Park, S.Y.3
Min, H.S.4
Kim, J.H.5
Kang, H.G.6
|